Home Baxalta

Baxalta

acquired
IPO Delisting
Biopharmaceutical company in the fields of hemophilia, immunology, and oncology

Basic Information

Baxalta Incorporated (Baxalta) is a biopharmaceutical company with a differentiated portfolio of therapies designed to address medical needs across various disease areas, including hemophilia, immunology, and oncology.
Baxalta, Inc.
Illinois,United States of America
more than 500 people
March 06, 2015
baxaltaconnect@baxalta.com